Literature DB >> 29425983

Primary Intracranial Angioleiomyomas as Rare, Nonmalignant, and Distinct Neoplastic Entities: A Series of 8 Cases and a Literature Review.

Cheng-Bei Li1, Ming-Guo Xie1, Jun-Peng Ma1, Liang Wang1, Shu-Yu Hao1, Li-Wei Zhang1, Wang Jia1, Gui-Jun Jia1, Jun-Ting Zhang1, Da Li2, Huan Li3, Zhen Wu4.   

Abstract

OBJECTIVE: Primary intracranial angioleiomyoma is a rare and distinct neoplasm. Only 29 cases have been reported previously, and we aimed to investigate the clinical and radiopathologic features of these lesions.
METHODS: Medical records and radiographs of 8 patients (7 male and 1 female; mean age: 48.7 years) at our institution were reviewed retrospectively. Patient follow-up and a literature review were performed.
RESULTS: The most common preoperative symptom was a visual defect (n = 2), followed by diplopia (n = 1) and abducens paralysis (n = 1). Three patients were asymptomatic. The parasellar area (particularly the cavernous sinus) was the predilection site (n = 4; 50.0%). Radiographically, all lesions were solid without cystic degeneration. All lesions appeared with T1 hypointensity and T2 hyperintensity, and they were gradually heterogeneously enhanced after the administration of gadolinium. Complete resection was achieved in 7 patients (87.5%) without recurrence after 26.8 months of follow-up. Mitosis was rarely observed, and the Ki-67 labeling index was less than 1%; pathologically, the cavernous type was the most common.
CONCLUSIONS: Primary intracranial angioleiomyomas were prevalent in middle-aged men, and they usually involved the cavernous sinus and were frequently pathologically identified as the cavernous type. Preoperative symptoms varied depending on lesion location. The preoperative diagnosis of primary intracranial angioleiomyomas is difficult without pathology. Digital subtraction angiography and preoperative embolization are useful for differential diagnosis and surgery. Given the indolent biology of these tumors, a favorable outcome can be achieved using total resection without recurrence. A larger sample size with long-term follow-up is needed to verify our findings.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cavernous sinus; Central nervous system; Neurosurgery; Primary intracranial angioleiomyoma

Mesh:

Year:  2018        PMID: 29425983     DOI: 10.1016/j.wneu.2018.01.207

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  4 in total

1.  The underestimated incidence of an orbital angioleiomyoma is possibly associated with an orbital cavernous hemangioma: illustrative case.

Authors:  Seonah Choi; JaeSang Ko; Se Hoon Kim; Eui Hyun Kim
Journal:  J Neurosurg Case Lessons       Date:  2021-05-24

2.  The dural angioleiomyoma harbors frequent GJA4 mutation and a distinct DNA methylation profile.

Authors:  Arnault Tauziède-Espariat; Thibaut Pierre; Michel Wassef; David Castel; Florence Riant; Jacques Grill; Alexandre Roux; Johan Pallud; Edouard Dezamis; Damien Bresson; Sandro Benichi; Thomas Blauwblomme; Djallel Benzohra; Guillaume Gauchotte; Celso Pouget; Sophie Colnat-Coulbois; Karima Mokhtari; Corinne Balleyguier; Frédérique Larousserie; Volodia Dangouloff-Ros; Nathalie Boddaert; Marie-Anne Debily; Lauren Hasty; Marc Polivka; Homa Adle-Biassette; Alice Métais; Emmanuèle Lechapt; Fabrice Chrétien; Felix Sahm; Philipp Sievers; Pascale Varlet
Journal:  Acta Neuropathol Commun       Date:  2022-05-31       Impact factor: 7.578

3.  Angioleiomyoma in the Orbital Apex: A Case Report.

Authors:  Boeun Lee; Soo Jeong Park; Ju Hyung Moon; Se Hoon Kim; Jong Hee Chang; Sun Ho Kim; Eui Hyun Kim
Journal:  Brain Tumor Res Treat       Date:  2019-10

4.  Skull Base Leiomyomas and Angioleiomyomas: A Systematic Literature Review and an Uncommon Case Report.

Authors:  Jordina Rincon-Torroella; M Harrison Snyder; Deepa J Galaiya; Meaghan Morris; Jon D Weingart; C Matthew Stewart
Journal:  World Neurosurg       Date:  2021-06-26       Impact factor: 2.210

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.